Neoadjuvant anti-OX40 (MEDI6469) prior to surgery in head and neck squamous cell carcinoma.

被引:13
|
作者
Bell, Richard Bryan [1 ]
Duhen, Rebekka [1 ]
Leidner, Rom S. [1 ]
Curti, Brendan D. [1 ]
Ballesteros-Merino, Carmen [1 ]
Piening, Brian [1 ]
Bernard, Brady [1 ]
Pucilowska, Joanna [1 ]
Bifulco, Carlo Bruno [1 ]
Fox, Bernard A. [1 ]
Duhen, Thomas [1 ]
Redmond, William L. [1 ]
Koguchi, Yoshinobu [1 ]
Cheng, Allen [1 ]
Patel, Ashish A. [1 ]
Morris, George [1 ]
Tamakawa, Raina [1 ]
Schuster, Mark W. [1 ]
Urba, Walter John [1 ]
Weinberg, Andrew D. [1 ]
机构
[1] Providence Canc Inst, Earle A Chiles Res Inst, Robert W Franz Canc Ctr, Portland, OR USA
关键词
D O I
10.1200/JCO.2018.36.15_suppl.6011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
6011
引用
收藏
页数:1
相关论文
共 50 条
  • [22] Immunological microenvironment in the clinical outcome of head and neck squamous cell carcinoma.
    Manikhas, Georgy M.
    Kutukova, Svetlana I.
    Belyak, Natalia P.
    Yaremenko, Andrey I.
    Raskin, Gregory
    Ermakova, Tatiana S.
    Bozhor, Svetlana S.
    Popova, Natalia V.
    Ivaskova, Julia V.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [23] The Role of MicroRNAs Expression Model in Head and Neck Squamous Cell Carcinoma.
    Slavik, M.
    Ahmad, P.
    Sana, J.
    Shatokhina, T.
    Kazda, T.
    Hermanova, M.
    Slampa, P.
    Slaby, O.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S1264 - S1264
  • [24] Methotrexate and cetuximab for metastatic advanced head and neck squamous cell carcinoma.
    Atassi, Bassel
    Yoo, George H.
    Robinette, Natasha
    Sibai, Khaled
    Sukari, Ammar
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [25] The study on molecular targets of classification of head and neck squamous cell carcinoma.
    Chen, Wantao
    Cao, Wei
    Zhang, Ping
    Cui, Zhibin
    Xu, Qin
    Wang, Xu
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [26] Functional characterization of chromosomal deletions in head and neck squamous cell carcinoma.
    Farhad, Ramin
    Palop, Vicente Planells
    Tward, Aaron
    CANCER RESEARCH, 2021, 81 (13)
  • [27] ADJUVANT CHEMOTHERAPY OF ADVANCED HEAD AND NECK SQUAMOUS-CELL CARCINOMA, PRIOR TO SURGERY AND RADIOTHERAPY
    MEDENICA, R
    LEHMANN, W
    PIPARD, G
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 430 - 430
  • [28] Delay to surgery after neoadjuvant chemotherapy in head and neck squamous cell carcinoma affects oncologic outcomes
    Kiong, Kimberley L.
    Yao, Christopher M. K. L.
    Lin, Fang-Yu
    Bell, Diana
    Ferrarotto, Renata
    Weber, Randal S.
    Lewis, Carol M.
    CANCER, 2021, 127 (12) : 1984 - 1992
  • [29] Commentary on, "Final analysis of a phase II trial of neoadjuvant chemoimmunotherapy for locoregionally advanced head and neck squamous cell carcinoma."
    Shanmugam, Geetha
    ORAL ONCOLOGY, 2024, 156
  • [30] Genomics and precision surgery for head and neck squamous cell carcinoma
    Galmiche, Antoine
    Saidak, Zuzana
    Bouaoud, Jebrane
    Mirghani, Haitham
    Page, Cyril
    Dakpe, Stephanie
    Clatot, Florian
    CANCER LETTERS, 2020, 481 : 45 - 54